$IMRX
Immuneering Corporation Class A Common Stock
XNAS
Why is IMRX up today? It is at $4.45 (+1.34%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMRX spikes, and full due diligence on IMRX — key stats, earnings, dilution and insider activity. Free.
Get free $IMRX alerts the moment volume spikes
Our scanner flagged $IMRX 6 times in the last 30 days. Create a free account to track $IMRX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $4.45
- Change today
- +1.34%
- Previous close
- $4.39
- 52-week range
- $2.90 – $10.08
- Market cap
- $114M
- Institutional own.
- 50.77%
- Total held
- 66.6%
- Tradeable float
- 21.6M 33% of shares · after 16% insiders + 51% institutions
- Short interest
- 15.2M ▲ +1% vs prior · as of 2026-07-15
- Short % of float
- 70.3%
- Days to cover
- 16.4d
- Avg daily volume
- 1.5M
- Next earnings
- Aug 12 · in 6d
- Exchange
- XNAS
- 5m
- 1.0x
- 15m
- 1.4x
- 1h
- 0.6x
- 1D
- 0.2x
Get free IMRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $IMRX up today?
Here is the latest on IMRX from our scanner (live price and day move above). Fresh from the SEC: Immuneering Corp filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Smart money in $IMRX
All smart money →- FAFisher Asset Management (Fisher) opened a new positionAs of Q2 2026 holdings · filed Aug 4, 2026$441K13F-HR ↗
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
Insiders
Insiders buying11 open-market buys2 buys, 0 sells last 3 months (17/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Zeskind Benjamin J. Officer | Bought (open market) | +2K | added 0.1% | 2.32M | $11K at $4.56 | Jun 23, 26 |
Hall Brett Matthew Officer | Bought (open market) | +6K 0.02% of company | added 1.6% | 383K | $25K at $4.15 | Jun 15, 26 |
Neufeld Leah R Officer | Acquired (grant/award) | +4K 0.01% of company | added 14% | 30K | $16K at $4.29 | Mar 13, 26 |
Brakewood Harold Eugene Officer | Bought (open market) | +5K 0.02% of company | added 91% | 11K | $25K at $4.76 | Jan 16, 26 |
Hall Brett Matthew Officer | Bought (open market) | +2K | added 0.6% | 376K | $11K at $4.57 | Jan 15, 26 |
Schall Thomas J. Director | Bought (open market) | +22K 0.08% of company | added 41% | 75K | $101K at $4.67 | Jan 15, 26 |
Neufeld Leah R Officer | Bought (open market) | +3K 0.01% of company | added 11% | 26K | $11K at $4.15 | Jan 13, 26 |
Feinberg Peter Director | Bought (open market) | +20K 0.08% of company | added 2.0% | 1.00M | $87K at $4.35 | Jan 12, 26 |
Feinberg Peter Director | Bought (open market) | +8K 0.03% of company | added 5.0% | 157K | $50K at $6.67 | Oct 3, 25 |
Bookman Michael Officer | Bought (open market) | +1K | added 26% | 5K | $7K at $6.83 | Oct 1, 25 |
Neufeld Leah R Officer | Bought (open market) | +800 | added 3.5% | 23K | $5K at $6.38 | Oct 1, 25 |
Morales Mallory Officer | Bought (open market) | +300 | added 1.1% | 28K | $2K at $6.39 | Oct 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$IMRX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$IMRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
IMRX stock FAQ
Why is $IMRX up today?
Here is the latest on IMRX from our scanner (live price and day move above). Fresh from the SEC: Immuneering Corp filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the IMRX stock price today?
IMRX last traded at $4.45, up 1.34% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does IMRX report earnings?
Immuneering Corporation Class A Common Stock (IMRX) is next expected to report earnings on Wednesday, August 12, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live IMRX alerts?
The IMRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMRX 6 times in the last 30 days.
What exchange is IMRX on?
IMRX (Immuneering Corporation Class A Common Stock) trades on XNAS, with a market cap of about $114M.
Is IMRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.